New tools for children with Type 1 diabetes

Article

Insulin analogs, advanced insulin pumps, and improved glucose monitoring devices make it easier to achieve glycemic control while decreasing the risk of hypoglycemia.

A little background

Pancreatic β-cells secrete insulin at a low basal rate that controls glucose levels in the fasting state; they also secrete increased amounts of insulin that control glucose levels after food intake. To normalize blood glucose levels in diabetics, administered insulin must replicate this endogenous basal-bolus pattern of insulin secretion.

Recombinant DNA technology allowed for structural modifications of insulin to alter its rate of absorption after subcutaneous injection. Thus, insulins could be designed with peaks and durations of action that would be better suited to provide either basal or bolus insulin needs.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
John Browning, MD, provides practical skincare reminders ahead of summer season
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Discussing phase 3 data of Panzyga for PANS, with Michael Daines, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
© 2025 MJH Life Sciences

All rights reserved.